問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

陳龍Chan, Lung
  • Principal Investigator
  • Clinical Trial Experience (year) 12 years 9 個月

篩選

List

11Cases

2019-10-01 - 2021-06-30

Phase II

A Phase IIa, Double-Blind, Single Dose, Randomized, Placebo-ControlledStudy to Evaluate the Safety, Tolerability, and Potential Efficacy of LT3001 Drug Product in Subjects with Acute Ischemic Stroke (AIS)
  • Condition/Disease

    Acute Ischemic Stroke

  • Test Drug

    LT3001 drug product

Participate Sites
6Sites

Recruiting4Sites

Study ended2Sites

1 2